Contraception
Volume 75, Issue 1 , Pages 45-51 , January 2007

Provider practice models for and costs of delivering medication abortion — evidence from 11 US abortion care settings

  • Aimee Afable-Munsuz

      Affiliations

    • University of California, San Francisco and Advancing New Standards in Reproductive Health (ANSIRH) program, Bixby Center for Reproductive Health Research & Policy, San Francisco, CA 94143, USA
    • Corresponding Author InformationCorresponding author. Institute for Health Policy Studies, University of California, San Francisco (UCSF), Box 0936, San Francisco, CA 94143, USA. Tel.: +1 415 476 1639; fax: +1 415 476 0705.
    • ,
  • Heather Gould

      Affiliations

    • University of California, San Francisco and Advancing New Standards in Reproductive Health (ANSIRH) program, Bixby Center for Reproductive Health Research & Policy, San Francisco, CA 94143, USA
    • ,
  • Felicia Stewart

      Affiliations

    • University of California, San Francisco and Advancing New Standards in Reproductive Health (ANSIRH) program, Bixby Center for Reproductive Health Research & Policy, San Francisco, CA 94143, USA
    • Department of Obstetrics, Gynecology and Reproductive Sciences, UCSF, San Francisco, CA 94143, USA
    • ,
  • Kathryn A. Phillips

      Affiliations

    • University of California, San Francisco and Advancing New Standards in Reproductive Health (ANSIRH) program, Bixby Center for Reproductive Health Research & Policy, San Francisco, CA 94143, USA
    • Department of Clinical Pharmacy, UCSF, San Francisco, CA 94143, USA
    • ,
  • Stephanie L. Van Bebber

      Affiliations

    • University of California, San Francisco and Advancing New Standards in Reproductive Health (ANSIRH) program, Bixby Center for Reproductive Health Research & Policy, San Francisco, CA 94143, USA
    • Department of Clinical Pharmacy, UCSF, San Francisco, CA 94143, USA
    • ,
  • Charlie Moore

      Affiliations

    • HealthMetrics, Inc., Bedford, MA 01730, USA

Received 17 March 2006 ,Revised 8 September 2006 ,Accepted 12 September 2006.

References 

  1. Finer LB, Henshaw S. Abortion incidence and services in the United States in 2000. Perspect Sex Reprod Health. 2003;35:6–15
  2. Danco Laboratories . For immediate release: July 18, 2005. from http://www.earlyoptionpill.com/pdfs/dancopress1.pdf[Accessed Dec 15, 2005]
  3. Prine L, Lesnewski R, Berley N, Gold M. Medical abortion in family practice: a case series. Am Board Fam Prac. 2003;16:290–295
  4. Schwartz B, Luetkemeyer A, Green Foster D, Weitz TA, Lindes D, Stewart F. Willing and able? Provision of medication for abortion by future internists. Women Health Issues. 2005;15:39–44
  5. Joffe C, Weitz TA. Normalizing the exceptional: incorporating the “abortion pill” into mainstream medicine. Soc Sci Med. 2003;56:2353–2366
  6. Stewart FH, Wells ES, Flinn SK, Weitz TA. Early medical abortion: issues for practice. San Francisco (CA): UCSF Center for Reproductive Health Research & Policy; 2001;
  7. Coeytaux F, Moore K, Gelberg L. Convincing new providers to offer medical abortion: what will it take?. Perspect Sex Reprod Health. 2003;35:44–47
  8. Seelig MD, Gelberg L, Tavrow P, Lee M, Rubenstein LV. Determinants of physician unwillingness to offer medical abortion using mifepristone. Women Health Issues. 2006;16:14–21
  9. Haddix AC, Corso PS, Gorsky RD. Costs. In:  Haddix AC,  Teutsch SM,  Corso PS editor. Prevention effectiveness: a guide to decision analysis and economic evaluation. 2nd ed.. New York: Oxford University Press, Inc; 2003;p. 53–76
  10. Ashok P, Penney G, Flett G, Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod. 1998;13:2962–2965
  11. Schaff EA, Eisinger SH, Stadalius LS, Fuller L. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception. 1999;59:1–6
  12. Newhall EP, Winikoff B. Abortion with mifepristone and misoprostol: regimens, efficacy, acceptability and future directions. Am J Obstet Gynecol. 2000;183:S44–S53
  13. Alan Guttmacher Institute . State policies in brief: mandatory counseling and waiting periods for abortion. Available at: http://www.agi-usa.org/statecenter/spibs/spib_MWPA.pdf[Accessed February 20, 2006]
  14. Alan Guttmacher Institute . State policies in brief: an overview of abortion laws. Available at: http://www.agi-usa.org/statecenter/spibs/spib_OAL.pdf[Accessed: February 20, 2006]
  15. Winikoff B. Acceptability of medical abortion in early pregnancy. Fam Plann Perspect. 1995;27:142–185
  16. Fielding SL, Edmunds E, Schaff E. Having an abortion using mifepristone and home misoprostol: a qualitative analysis of women's experiences. Perspect Sex Reprod Health. 2002;34:34–40
  17. Murthy A, Creinin M. Pharmacoeconomics of medical abortion: a review of cost in the United States, Europe and Asia. Expert Opin Pharmacother. 2003;4:503–513

PII: S0010-7824(06)00364-7

doi: 10.1016/j.contraception.2006.09.009

Contraception
Volume 75, Issue 1 , Pages 45-51 , January 2007

Article Tools